NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

https://www.sec.gov/Archives/edgar/data/0001072379/000114420416134282/v453089_8k.htm

Not to hard to find.

As previously reported, on June 24, 2016 the Company was advised by the Nasdaq Staff that by effecting a reverse stock split, if necessary, and satisfying any other applicable requirementsit no longer meets the $1.00 per share requirement for continued listing pursuant to Nasdaq Listing Rule 5550(a)(2) and was granted a grace period through December 21, 2016 in which to regain compliance. Compliance can be achieved by maintaining a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days. If the Company does not regain compliance by December 21, 2016, the Company may be eligible for a second 180-day grace period if it meets the initial listing standards (with the exception of the bid price and market value of publicly held shares requirements) for The Nasdaq Capital Market, which the Company does not currently meet, and provides written notice to Nasdaq of its intention to cure the deficiency during the second 180-day grace period, by effecting a reverse stock split, if necessary, and satisfying any other applicable requirements. If the Company does not regain compliance by December 21, the Staff would issue a notice of delisting and the Company would at that time have the opportunity to request a hearing in accordance with the above-described procedures.